Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrascom Inv Regulatory News (OIH)

  • This share is currently suspended. It was suspended at a price of 0.014

Share Price Information for Orascom Inv (OIH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.014
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.014
OIH Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OIH OGM Invitation

30 Apr 2024 08:46

RNS Number : 5710M
Orascom Investment Holding S.A.E
30 April 2024
 

Invitation

To attend the Ordinary General Assembly Meeting of

Orascom Investment Holding S.A.E

To convene on Sunday, 26/5/2024

In light of the Ministerial Decree no. 606 of 2020, and after reviewing the circular issued by the Financial Regulator Authority, and the Decree issued by the General Authority for Investment and Free Zones no. 160 of 2020 regarding the virtual attendance of the general assemblies, the Chairman of the Board of Directors of Orascom Investment Holding SAE (the "Company") has the honor to invite the shareholders, the board members, the Financial Regulatory Authority, the General Authority for Investment and Free Zones and the Company's Auditor to attend the Ordinary General Assembly Meeting ("OGM") that will convene on Sundy, 26/5/2024, at 02:30 PM, via conference call, through the following link: (http://zoom.us/j/81219596048?)

To discuss the following agenda:

1. Ratification of the Board of Directors' report on the Company's activities during the fiscal year ending on 31/12/2023;

2. Ratification of the Auditor's report on the Company's activities for the fiscal year ending on 31/12/2023;

3. Ratification of the financial statements and the distribution of the dividends for the fiscal year ending on 31/12/2023;

4. Ratification of the Corporate Governance Report for the fiscal year ending on 31/12/2023;

5. Ratify the Board of Directors resolutions during the fiscal year ending on 31/12/2023;

6. Discharge the Chairman and Members of the Board of Directors for their duties during the fiscal year ending on 31/12/2023;

7. Determining the remuneration, attendance and transportation allowances of the Board Members for the year 2024;

8. Approve the appointment of the Company's Auditor for the fiscal year ended 31/12/2024 and determine his fees;

9. Authorize the Board to enter into loans, mortgages, pledges and issue guarantees and warranties to lenders and co-contracting parties for the Company and the subsidiaries under its control as well as delegating the Board to enter into related party agreements with the Company's subsidiaries; and

10. Approve the donations made during the fiscal year ending on 31/12/2023 and authorize the Board to donate during the fiscal year ending on 31/12/2024.

We would like to highlight the following to the shareholders of the Company:

1. The shareholders who wish to attend OGM are kindly requested to send the following documents to: (shareholders@OrascomIH.com):

- A certified account statement issued by one of the custodians' banks, evidencing the freezing of the shares outlined in the account statement for the purpose of attending the OGM. The shareholder shall provide the Company with the aforementioned statement by at least 3 days before the date of OGM. Each shareholder has the right to attend the meeting in person or on behalf of another shareholder who is not a member of the Board of Directors, and the delegation in that case shall only be valid if made in writing by virtue of a proxy or a Power of Attorney.

- National ID or passport to prove the identity of the shareholder.

The Company will respond to the shareholders in the same way as soon as all the documents above are reviewed and verified and shall send to the shareholder the meeting password that will enable him to join the meeting via conference call, as well as the voting card to vote on it.

2. A shareholder must fill out the voting card sent to him with his personal data, the number of shares, the capacity of attendance, his vote on the resolutions presented to the assembly and his signature on them, and he must resend it to the above-mentioned e-mail before the date of the OGM.

3. A shareholder who voted before the assembly was held may change his vote while attending the meeting on the meeting day.

4. The shareholder voting remotely do not have the right give proxy to vote, as the voting must be done remotely by the owner shareholder, in accordance with the decision of the Board of Directors of the Financial Supervisory Authority No. (150) of 2022.

5. Any questions related to the topics presented to the ordinary general assembly must be delivered in return of a receipt to the Company's financial department or to the above-mentioned e-mail, at least five days before the meeting.

6. The meeting of the OGM shall not be valid unless if attended by shareholders representing at least one quarter of the shares of the Company's capital. In the event the quorum is not met, the second meeting will be held on Sunday, 2/6/2024 at 02:00 PM in the afternoon at the Company's headquarters via conference call through the following link (http://zoom.us/j/88608322643?). The second meeting shall be deemed valid regardless of the number of shares represented in the meeting.

7. Resolutions of the Ordinary General Assembly shall be issued by an absolute majority of the shares represented in the meeting.

8. The Ordinary General Assembly may not deliberate on matters other than those listed on the agenda.

 

Chairman

Naguib Sawiris

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGRGDSCXXDGSG
Date   Source Headline
29th Oct 20123:45 pmRNSSecond Price Monitoring Extn
29th Oct 20123:40 pmRNSPrice Monitoring Extension
15th Oct 20123:45 pmRNSSecond Price Monitoring Extn
15th Oct 20123:40 pmRNSPrice Monitoring Extension
15th Oct 20127:00 amRNSOTMT Assign to FT its GSA with ECMS
11th Oct 20123:45 pmRNSSecond Price Monitoring Extn
11th Oct 20123:40 pmRNSPrice Monitoring Extension
20th Aug 20126:11 pmRNSAcquisition effective date & listing cancellation
17th Aug 20126:01 pmRNSUpdate re recommended cash acquisition
10th Aug 20123:45 pmRNSSecond Price Monitoring Extn
10th Aug 20123:40 pmRNSPrice Monitoring Extension
27th Jul 20127:00 amRNSUpdate re recommended cash acquisition
16th Jul 20123:45 pmRNSSecond Price Monitoring Extn
16th Jul 20123:40 pmRNSPrice Monitoring Extension
6th Jul 201212:49 pmRNSResponse to announcement by Mr John Robinson
3rd Jul 20124:43 pmRNSDividend Declaration
29th Jun 20127:00 amRNSRelease of audited IFRS results for FY 2011
28th Jun 20125:49 pmRNSOGM Press Release 28-6-2012
26th Jun 20129:51 amRNSADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE
25th Jun 20125:06 pmRNSOTMT expected admission Date
25th Jun 20127:00 amRNSFurther re Recommended Cash Acquisition
20th Jun 20125:39 pmRNSPublication of Prospectus
12th Jun 20129:36 amRNSStepping Down of CEO
7th Jun 20122:50 pmRNSResult of Special General Meeting
6th Jun 20123:45 pmRNSSecond Price Monitoring Extn
6th Jun 20123:40 pmRNSPrice Monitoring Extension
1st Jun 20123:40 pmRNSPrice Monitoring Extension
31st May 20123:45 pmRNSSecond Price Monitoring Extn
31st May 20123:40 pmRNSPrice Monitoring Extension
25th May 20126:09 pmRNSHolding(s) in Company
16th May 20127:00 amRNSInterim Management Statement
14th May 20125:36 pmRNSPosting of Circular
10th May 20122:32 pmRNSResult of AGM
3rd May 201212:51 pmRNSAnnual Information Update
2nd May 20129:40 amRNSForm 8.3 - Omega Insurance Holdings Limited
30th Apr 20129:33 amRNSForm 8.3 - Omega Insurance Holdings Ltd
27th Apr 20122:17 pmRNSHolding(s) in Company
27th Apr 201210:17 amRNSForm 8.3 - OMEGA INSURANCE HOLD LTD
25th Apr 20126:22 pmRNSOffer for Omega Insurance Holdings Limited
13th Apr 201211:52 amRNSHolding(s) in Company
12th Apr 20128:03 amRNSFT and OTMT Joint Announcement
11th Apr 20126:05 pmRNSAnnual Financial Report
30th Mar 20124:41 pmRNSSecond Price Monitoring Extn
30th Mar 20124:35 pmRNSPrice Monitoring Extension
29th Mar 20126:10 pmRNSHolding(s) in Company
29th Mar 20125:55 pmRNSDirector/PDMR Shareholding
27th Mar 20124:11 pmRNSStatement re. Press Comment
14th Mar 20127:00 amRNSHolding(s) in Company
6th Mar 20127:00 amRNSFinal Results
24th Jan 201210:59 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.